출판 : MarketsandMarkets（마켓츠앤드마켓츠）출판년월 : 2022년04월
디지털 당뇨병 관리 시장 : 제품[디바이스(스마트 혈당계, CGM, 인슐린 패치 펌프), 당뇨병 앱, 서비스, 데이터 관리 소프트웨어], 디바이스 타입(핸드헬드, 웨어러블), 최종 사용자(병원, 셀프/홈 헬스케어) – 2027년까지의 세계 예측
Digital Diabetes Management Market by Product (Device (Smart Glucometer, CGM, Insulin Patch Pump), Diabetes Apps, Service, Data Management Software), Device Type (Handheld & Wearables), End User (Hospitals & Self/home healthcare) – Global Forecast to 2027
| 페이지수 | 227 |
| 도표수 | 253 |
| 구성 | 영문조사보고서 |
| 가격 |
The global digital diabetes management market is projected to reach USD 25.5 Billion by 2027 from an estimated USD 14.3 Billion in 2022, at a CAGR of 12.2% during the forecast period. The rising prevalence of diabetes has increased the focus on the development and adoption of better solutions for diabetes care. Also, advancements in technologies have ensured the introduction of highly flexible solutions in the market.
세계 디지털 당뇨병 관리 시장은 예측 기간 동안 12.2%의 CAGR로 2022년 143억 달러에서 2027년 255억 달러에 이를 것으로 예상됩니다. 증가하는 당뇨병 유병률은 당뇨병 관리를 위한 더 나은 솔루션의 개발 및 채택에 대한 초점을 증가시켰습니다. 또한 기술의 발전으로 인해 시장에 매우 유연한 솔루션의 도입이 보장되었습니다.
The increasing adoption of cloud-based enterprise solutions and the growing use of connected devices and apps are some of the other major factors supporting market growth.
클라우드 기반 엔터프라이즈 솔루션의 채택 증가와 연결된 장치 및 앱의 사용 증가는 시장 성장을 지원하는 다른 주요 요인 중 일부입니다.
However, factors such as the high device costs, lack of reimbursement in developing countries, and the higher acceptance of traditional diabetes management devices are expected to restrain the growth of this market during the forecast period.
“Smart glucose meters segment accounted for the largest share in the Digital Diabetes Management market.”
The devices segment is categorized into smart glucose meters, CGM systems, smart insulin pens, and smart insulin pumps/closed-loop systems & smart insulin patches. In 2021, the smart glucose meters segment accounted for a share of 25.2% of the digital diabetes management devices market. The growth of this segment is mainly attributed to the easy handling of smart glucose meters, as well as their benefits in the early detection of hypo and hyperglycemic diabetes. Technological innovations, such as all-in-one glucometers with analysis capabilities, Bluetooth-enabled glucometers, and portable pocket-size glucometers are some of the other factors driving the growth of this market segment.
“Wearable devices segment to grow at the highest CAGR during the forecast period.”
Various devices considered in the digital diabetes management devices market are categorized into handheld devices and wearable devices. Wearable devices accounted for the largest share of 60.3% of the digital diabetes management devices market in 2021. This segment is estimated to grow at the highest CAGR of 13.2% during the forecast period. The increasing number of regulatory approvals for wearables, technological advancements, and the growing adoption of smart insulin pumps and insulin patches are driving the growth of the wearables market.
“The Self/home healthcare segment accounted for the largest share of Digital Diabetes Management market in 2021”
The self/home healthcare segment accounted for the largest share of the digital diabetes management market in 2021. This is mainly attributed to the growing patient acceptability of home care due to the increasing awareness of digital diabetes management platforms. Self-administration is especially useful for patients who require regular insulin therapy. For patients requiring long-term therapy, inpatient care is not only extremely expensive but also prevents them from resuming a normal lifestyle.
“North America accounted for the largest share of the Digital Diabetes Management market in 2021”
In 2021, North America accounted for the largest market share of 41.4%, followed by Europe with a share of 29.0%. North America dominates the digital diabetes management market, mainly due to the growing adoption of connected diabetes management devices, increasing adoption of diabetes management and obesity apps, growing demand for technologically advanced solutions, increased acceptance of digital diabetes solutions from payers, government initiatives to promote digital health, and rising awareness on self-diabetes management in the region.
A breakdown of the primary participants (supply-side) for the Digital Diabetes Management market referred to for this report is provided below:
• By Company Type: Tier 1–46%, Tier 2–33%, and Tier 3–21%
• By Designation: C-level–43%, Director Level–35%, and Others–22%
• By Region: North America–34%, Europe–26%, Asia Pacific–19%, Latin America- 11%, and Middle East and Africa– 10%
The prominent players operating in the global digital diabetes management market are Medtronic (Ireland), B. Braun Melsungen AG (Germany), Dexcom, Inc. (US), Abbott Laboratories (US), F. Hoffmann-La Roche (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care Holdings AG (Switzerland), LifeScan, Inc. (US), Tidepool (US), AgaMatrix (US), Glooko, Inc. (US), DarioHealth Corporation (Israel), One Drop (US), Dottli (Finland), Ypsomed Holding AG (Switzerland), ARKRAY (Japan), ACON Laboratories, Inc. (US), Care Innovations, LLC (US), Health2Sync (Taiwan), Emperra GmbH E-Health Technologies (Germany), Azumio (US), Decide Clinical Software GmbH (Austria), Pendiq GmbH (Germany), and BeatO (India).
Research Coverage:
The market study covers the digital diabetes management market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product & service, by device type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the digital diabetes management market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.
목차
TABLE OF CONTENTS
1 INTRODUCTION (Page No. – 31)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
TABLE 1 STANDARD CURRENCY CONVERSION RATES
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. – 36)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021)
FIGURE 6 MARKET SIZE ESTIMATION: COMPANY-WISE REVENUE SHARE ANALYSIS (2021)
FIGURE 7 SUPPLY-SIDE ANALYSIS: DIGITAL DIABETES MANAGEMENT MARKET (2021)
FIGURE 8 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE DIGITAL DIABETES MANAGEMENT MARKET
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE DIGITAL DIABETES MANAGEMENT MARKET
FIGURE 10 TOP-DOWN APPROACH: GLOBAL DIGITAL DIABETES MANAGEMENT MARKET
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. – 49)
FIGURE 12 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 13 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 15 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 16 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 17 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS (Page No. – 54)
4.1 DIGITAL DIABETES MANAGEMENT MARKET OVERVIEW
FIGURE 18 INCREASING PREVALENCE OF DIABETES AND GROWING DEMAND FOR DIGITAL SOLUTIONS ARE DRIVING MARKET GROWTH
4.2 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021)
FIGURE 19 DEVICES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN THE ASIA PACIFIC MARKET
4.3 DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
FIGURE 20 THE US MARKET IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
4.4 REGIONAL MIX: DIGITAL DIABETES MANAGEMENT MARKET
FIGURE 21 NORTH AMERICAN MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
4.5 DIGITAL DIABETES MANAGEMENT MARKET: DEVELOPING VS. DEVELOPED MARKETS, 2022 VS. 2027 (USD MILLION)
FIGURE 22 DEVELOPED MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. – 58)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 DIGITAL DIABETES MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing prevalence of diabetes
TABLE 2 TOP FIVE COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (20–79 YEARS), 2021 VS. 2045
5.2.1.2 Technological advancements
5.2.1.3 Growing adoption of cloud-based enterprise solutions for diabetes management
5.2.1.4 Use of artificial intelligence in diabetes care devices
5.2.2 RESTRAINTS
5.2.2.1 High cost of devices and lack of reimbursement in developing countries
5.2.2.2 Higher acceptance of traditional diabetes management devices
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing diabetes-related health expenditure
5.2.4 CHALLENGES
5.2.4.1 Low penetration in developing economies
5.2.4.2 Lack of data security
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 3 DIGITAL DIABETES MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 PATENT ANALYSIS
5.4.1 PATENT PUBLICATION TRENDS FOR DIGITAL DIABETES MANAGEMENT
5.4.2 TOP APPLICANTS (COMPANIES) FOR DIGITAL DIABETES MANAGEMENT PATENTS
FIGURE 24 TOP APPLICANT COMPANIES FOR DIGITAL DIABETES MANAGEMENT PATENTS, 2016–2021
5.4.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR DIGITAL DIABETES MANAGEMENT PATENTS
FIGURE 25 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR DIGITAL DIABETES MANAGEMENT PATENTS, 2016–2021
5.5 TECHNOLOGY ANALYSIS
5.6 AVERAGE SELLING PRICE TRENDS
TABLE 4 AVERAGE SELLING PRICE OF SMARTPHONE-CONNECTED INSULIN PUMPS, BY REGION, 2021
TABLE 5 AVERAGE SELLING PRICE OF SENSOR-BASED CONTINUOUS GLUCOSE MONITORS, BY REGION, 2021
5.7 VALUE CHAIN ANALYSIS
FIGURE 26 DIGITAL DIABETES MANAGEMENT MARKET: VALUE CHAIN ANALYSIS (2021)
5.8 ECOSYSTEM MAP
FIGURE 27 DIGITAL DIABETES MANAGEMENT MARKET: ECOSYSTEM MAP (2021)
5.9 KEY CONFERENCES & EVENTS IN 2022–2023
TABLE 6 DIGITAL DIABETES MANAGEMENT MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.10 INDUSTRY TRENDS
5.10.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS
TABLE 7 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO
5.10.2 GROWING NUMBER OF COLLABORATIONS BETWEEN STAKEHOLDERS
TABLE 8 RECENT COLLABORATIONS IN THE DIGITAL DIABETES MANAGEMENT MARKET
5.10.3 INCREASING DEMAND FOR FLASH GLUCOSE MONITORING (FGM) SYSTEMS
5.11 REGULATORY ANALYSIS
TABLE 9 INDICATIVE LIST OF REGULATORY AUTHORITIES
5.11.1 NORTH AMERICA
5.11.1.1 US
TABLE 10 US: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
FIGURE 28 FDA 510(K) APPROVAL PROCESS
5.11.1.2 Canada
TABLE 11 CANADA: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
5.11.2 EUROPE
FIGURE 29 CE MARK APPROVAL PROCESS FOR DIGITAL DIABETES MANAGEMENT SOLUTIONS
5.11.3 ASIA PACIFIC
5.11.3.1 Australia
5.11.3.2 Japan
TABLE 12 CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN
5.11.3.3 China
TABLE 13 CHINA: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
5.11.3.4 India
5.11.4 LATIN AMERICA
5.12 REIMBURSEMENT SCENARIO
TABLE 14 DIGITAL DIABETES MANAGEMENT PRODUCTS: GLOBAL COVERAGE AND REIMBURSEMENT
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 30 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
TABLE 15 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR TOP 3 APPLICATIONS (%)
5.13.2 BUYING CRITERIA
FIGURE 31 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
TABLE 16 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
5.14 ASSESSMENT OF COVID-19 IMPACT ON THE ECONOMIC SCENARIO IN THE DIGITAL DIABETES MANAGEMENT MARKET
6 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE (Page No. – 80)
6.1 INTRODUCTION
TABLE 17 DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
6.2 DEVICES
TABLE 18 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 19 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1 SMART GLUCOSE METERS
6.2.1.1 Reducing prices and technological innovations to drive segment growth
TABLE 20 KEY SMART GLUCOSE METERS AVAILABLE IN THE MARKET
TABLE 21 SMART GLUCOSE METERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS
6.2.2.1 CGM segment to grow at the highest CAGR during the forecast period
TABLE 22 KEY CGM SYSTEMS AVAILABLE IN THE MARKET
TABLE 23 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 SMART INSULIN PENS
6.2.3.1 Increasing demand for personalized or patient-centric devices without needle-stick injuries to drive segment growth
TABLE 24 KEY SMART INSULIN PENS AVAILABLE IN THE MARKET
TABLE 25 SMART INSULIN PENS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.4 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS & SMART INSULIN PATCHES
6.2.4.1 Benefits of smart insulin pumps and closed-loop systems to drive segment growth
TABLE 26 KEY SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS & SMART INSULIN PATCHES AVAILABLE IN THE MARKET
TABLE 27 SMART INSULIN PUMPS/CLOSED-LOOP SYSTEMS & SMART INSULIN PATCHES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 DIGITAL DIABETES MANAGEMENT APPS
TABLE 28 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 29 DIGITAL DIABETES MANAGEMENT APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.1 DIABETES & BLOOD GLUCOSE TRACKING APPS
6.3.1.1 Growing adoption of connected devices to drive segment growth
TABLE 30 KEY DIABETES & BLOOD GLUCOSE TRACKING APPS AVAILABLE IN THE MARKET
TABLE 31 DIABETES & BLOOD GLUCOSE TRACKING APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.2 WEIGHT & DIET MANAGEMENT APPS
6.3.2.1 Growing obese population and the increasing need to prevent diabetes to drive segment growth
TABLE 32 KEY WEIGHT & DIET MANAGEMENT APPS AVAILABLE IN THE MARKET
TABLE 33 WEIGHT & DIET MANAGEMENT APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 DATA MANAGEMENT SOFTWARE & PLATFORMS
6.4.1 GROWING DEMAND FOR DIABETES DATA MANAGEMENT TO DRIVE SEGMENT GROWTH
TABLE 34 KEY DATA MANAGEMENT SOFTWARE & PLATFORMS AVAILABLE IN THE MARKET
TABLE 35 DATA MANAGEMENT SOFTWARE & PLATFORMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 SERVICES
6.5.1 INCREASING ADOPTION OF REMOTE ONLINE COACHING SERVICES AMONG DIABETES PATIENTS TO DRIVE SEGMENT GROWTH
TABLE 36 KEY SERVICES AVAILABLE IN THE MARKET
TABLE 37 DIGITAL DIABETES MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE (Page No. – 101)
7.1 INTRODUCTION
TABLE 38 DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
7.2 WEARABLE DEVICES
7.2.1 WEARABLE DEVICES DOMINATE THE DIGITAL DIABETES MANAGEMENT DEVICES MARKET
TABLE 39 WEARABLE DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 HANDHELD DEVICES
7.3.1 INCREASING DEMAND FOR REMOTE MONITORING TO BOOST SEGMENT GROWTH
TABLE 40 HANDHELD DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER (Page No. – 105)
8.1 INTRODUCTION
TABLE 41 DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 SELF/HOME HEALTHCARE
8.2.1 HIGH COST OF INPATIENT CARE HAS FUELED THE PREFERENCE FOR SELF/HOME CARE
TABLE 42 DIGITAL DIABETES MANAGEMENT MARKET FOR SELF/HOME HEALTHCARE, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 HOSPITALS & SPECIALTY DIABETES CLINICS
8.3.1 RISING DEMAND FOR POC TESTING IN HOSPITALS TO BOOST SEGMENT GROWTH
TABLE 43 DIGITAL DIABETES MANAGEMENT MARKET FOR HOSPITALS & SPECIALTY DIABETES CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 PRODUCT INNOVATION FOR DIABETES MANAGEMENT TO DRIVE SEGMENT GROWTH
TABLE 44 DIGITAL DIABETES MANAGEMENT MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
9 DIGITAL DIABETES MANAGEMENT MARKET, BY REGION (Page No. – 110)
9.1 INTRODUCTION
FIGURE 32 GEOGRAPHIC SNAPSHOT: MARKETS IN ASIA PACIFIC ARE EMERGING HOTSPOTS
TABLE 45 DIGITAL DIABETES MANAGEMENT MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 33 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT
TABLE 46 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 48 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 49 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 50 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 51 NORTH AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Increasing diabetes prevalence and high penetration of digital platforms have boosted the growth of the US market
TABLE 52 US: MACROECONOMIC INDICATORS
TABLE 53 US: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 54 US: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 55 US: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 US: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 US: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Favorable reimbursement scenario has contributed to the use of digital diabetes management in Canada
TABLE 58 CANADA: MACROECONOMIC INDICATORS
TABLE 59 CANADA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 60 CANADA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 61 CANADA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 62 CANADA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 63 CANADA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
FIGURE 34 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT
TABLE 64 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 65 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 66 EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 67 EUROPE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 EUROPE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 69 EUROPE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany accounted for the largest share of the European digital diabetes management market in 2021
TABLE 70 GERMANY: MACROECONOMIC INDICATORS
TABLE 71 GERMANY: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 72 GERMANY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 73 GERMANY: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 74 GERMANY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 75 GERMANY: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 Supportive government initiatives have contributed to the growth of the UK market
TABLE 76 UK: MACROECONOMIC INDICATORS
TABLE 77 UK: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 78 UK: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 79 UK: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 80 UK: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 UK: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Affordability of healthcare in France has contributed to the adoption of digital solutions
TABLE 82 FRANCE: MACROECONOMIC INDICATORS
TABLE 83 FRANCE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 84 FRANCE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 85 FRANCE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 FRANCE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 FRANCE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing prevalence of diabetes to provide growth opportunities for market players in Italy
TABLE 88 ITALY: MACROECONOMIC INDICATORS
TABLE 89 ITALY: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 90 ITALY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 91 ITALY: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 ITALY: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 ITALY: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Growing healthcare budget and rising efforts for boosting the local manufacturing of medical products to drive market growth
TABLE 94 SPAIN: MACROECONOMIC INDICATORS
TABLE 95 SPAIN: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 96 SPAIN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 97 SPAIN: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 SPAIN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 SPAIN: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 100 ROE: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 101 ROE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 102 ROE: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 ROE: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 ROE: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 35 ASIA PACIFIC: DIGITAL DIABETES MANAGEMENT MARKET SNAPSHOT
TABLE 105 APAC: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 106 APAC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 107 APAC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 108 APAC: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 APAC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 APAC: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 High acceptance of digital solutions for diabetes management driving market growth in Japan
TABLE 111 JAPAN: MACROECONOMIC INDICATORS
TABLE 112 JAPAN: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 113 JAPAN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 114 JAPAN: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 JAPAN: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 JAPAN: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Rising awareness about self-diabetes management among geriatric population driving market growth in China
TABLE 117 CHINA: MACROECONOMIC INDICATORS
TABLE 118 CHINA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 119 CHINA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 120 CHINA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 121 CHINA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 CHINA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing burden of diabetes and increasing need to reduce rising healthcare costs have boosted the adoption of digital platforms
TABLE 123 INDIA: MACROECONOMIC INDICATORS
TABLE 124 INDIA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 125 INDIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 126 INDIA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 127 INDIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 128 INDIA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Initiatives to help treat or manage diabetes-related problems to drive market growth in Australia
TABLE 129 AUSTRALIA: MACROECONOMIC INDICATORS
TABLE 130 AUSTRALIA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 131 AUSTRALIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 132 AUSTRALIA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 AUSTRALIA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 AUSTRALIA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC
TABLE 135 ROAPAC: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 136 ROAPAC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 137 ROAPAC: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 ROAPAC: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 ROAPAC: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
TABLE 140 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 141 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 142 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 143 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 145 LATIN AMERICA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 High private healthcare expenditure and increasing geriatric population driving market growth in Brazil
TABLE 146 BRAZIL: MACROECONOMIC INDICATORS
TABLE 147 BRAZIL: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 148 BRAZIL: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 149 BRAZIL: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 BRAZIL: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 BRAZIL: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Growing obesity rate in Mexico to drive market growth
TABLE 152 MEXICO: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 153 MEXICO: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 154 MEXICO: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 MEXICO: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 156 MEXICO: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 157 ROLATAM: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 158 ROLATAM: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 159 ROLATAM: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 160 ROLATAM: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 ROLATAM: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 DIGITIZATION OF HEALTH SYSTEMS IN AFRICAN COUNTRIES HAS YET TO PICK UP PACE
TABLE 162 AFRICA: MACROECONOMIC INDICATORS
TABLE 163 MEA: DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 164 MEA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY PRODUCT TYPE, 2020–2027 (USD MILLION)
TABLE 165 MEA: DIGITAL DIABETES MANAGEMENT APPS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 MEA: DIGITAL DIABETES MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 167 MEA: DIGITAL DIABETES MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. – 167)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 36 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE DIGITAL DIABETES MANAGEMENT MARKET
10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN THE DIGITAL DIABETES MANAGEMENT MARKET
FIGURE 37 REVENUE SHARE ANALYSIS OF KEY PLAYERS OPERATING IN THE DIGITAL DIABETES MANAGEMENT MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 38 MARKET SHARE ANALYSIS: CONTINUOUS GLUCOSE MONITORING DEVICES (2021)
FIGURE 39 MARKET SHARE ANALYSIS: INSULIN PUMPS MARKET (2021)
FIGURE 40 MARKET SHARE ANALYSIS: SMART INSULIN PENS MARKET (2021)
FIGURE 41 MARKET SHARE ANALYSIS: DIABETES APPS MARKET (2021)
10.5 R&D ASSESSMENT OF KEY PLAYERS
FIGURE 42 R&D EXPENDITURE: KEY PLAYERS IN THE DIGITAL DIABETES MANAGEMENT MARKET, 2019, 2020, AND 2021
10.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS
FIGURE 43 GEOGRAPHIC REVENUE ASSESSMENT: DIGITAL DIABETES MANAGEMENT MARKET (2021)
10.7 COMPANY EVALUATION QUADRANT
FIGURE 44 DIGITAL DIABETES MANAGEMENT MARKET: COMPANY EVALUATION MATRIX, 2021
10.7.1 STARS
10.7.2 EMERGING LEADERS
10.7.3 PERVASIVE PLAYERS
10.7.4 PARTICIPANTS
10.8 COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS
FIGURE 45 DIGITAL DIABETES MANAGEMENT MARKET: COMPANY EVALUATION MATRIX FOR SMES & START-UPS
10.8.1 PROGRESSIVE COMPANIES
10.8.2 DYNAMIC COMPANIES
10.8.3 STARTING BLOCKS
10.8.4 RESPONSIVE COMPANIES
10.9 COMPETITIVE BENCHMARKING
10.9.1 OVERALL COMPANY FOOTPRINT
TABLE 168 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
TABLE 169 COMPANY FOOTPRINT: BY PRODUCT & SERVICE (25 COMPANIES)
TABLE 170 COMPANY FOOTPRINT: BY DEVICE TYPE (25 COMPANIES)
TABLE 171 COMPANY FOOTPRINT: BY END USER (25 COMPANIES)
TABLE 172 COMPANY FOOTPRINT: BY REGION (25 COMPANIES)
10.10 COMPETITIVE SCENARIO
10.10.1 PRODUCT LAUNCHES
TABLE 173 PRODUCT LAUNCHES (2020–2022)
10.10.2 DEALS
TABLE 174 DEALS (2020–2021)
11 COMPANY PROFILES (Page No. – 184)
11.1 KEY PLAYERS
(Business overview, Products & services offered, Recent developments, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats)*
11.1.1 MEDTRONIC PLC
FIGURE 46 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
11.1.2 F. HOFFMANN-LA ROCHE
TABLE 176 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW
FIGURE 47 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2021)
11.1.3 DEXCOM, INC.
TABLE 177 DEXCOM, INC.: BUSINESS OVERVIEW
FIGURE 48 DEXCOM, INC.: COMPANY SNAPSHOT (2021)
11.1.4 ASCENSIA DIABETES CARE HOLDINGS AG
TABLE 178 ASCENSIA DIABETES CARE HOLDINGS AG: BUSINESS OVERVIEW
11.1.5 ABBOTT LABORATORIES
TABLE 179 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 49 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)
11.1.6 B. BRAUN MELSUNGEN AG
TABLE 180 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
FIGURE 50 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2021)
11.1.7 TIDEPOOL
TABLE 181 TIDEPOOL: BUSINESS OVERVIEW
11.1.8 GLOOKO, INC.
TABLE 182 GLOOKO: BUSINESS OVERVIEW
11.1.9 LIFESCAN, INC.
TABLE 183 LIFESCAN, INC.: BUSINESS OVERVIEW
11.1.10 AGAMATRIX, INC.
TABLE 184 AGAMATRIX, INC.: BUSINESS OVERVIEW
11.1.11 TANDEM DIABETES CARE, INC.
TABLE 185 TANDEM DIABETES CARE: BUSINESS OVERVIEW
FIGURE 51 TANDEM DIABETES CARE: COMPANY SNAPSHOT (2021)
11.1.12 INSULET CORPORATION
TABLE 186 INSULET CORPORATION: BUSINESS OVERVIEW
FIGURE 52 INSULET CORPORATION: COMPANY SNAPSHOT (2021)
11.1.13 DARIOHEALTH CORPORATION
TABLE 187 DARIOHEALTH CORPORATION: BUSINESS OVERVIEW
FIGURE 53 DARIOHEALTH CORPORATION: COMPANY SNAPSHOT (2021)
11.1.14 ONE DROP
TABLE 188 ONE DROP: BUSINESS OVERVIEW
11.1.15 DOTTLI
TABLE 189 DOTTLI: BUSINESS OVERVIEW
11.1.16 YPSOMED HOLDING AG
TABLE 190 YPSOMED HOLDING AG: BUSINESS OVERVIEW
FIGURE 54 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2021)
11.1.17 ARKRAY, INC.
TABLE 191 ARKRAY, INC.: BUSINESS OVERVIEW
11.1.18 ACON LABORATORIES, INC.
TABLE 192 ACON LABORATORIES, INC.: BUSINESS OVERVIEW
11.1.19 CARE INNOVATIONS, LLC
TABLE 193 CARE INNOVATIONS, LLC: BUSINESS OVERVIEW
11.1.20 HEALTH2SYNC
TABLE 194 HEALTH2SYNC: BUSINESS OVERVIEW
11.1.21 EMPERRA GMBH E-HEALTH TECHNOLOGIES
TABLE 195 EMPERRA GMBH E-HEALTH TECHNOLOGIES: BUSINESS OVERVIEW
11.1.22 AZUMIO
TABLE 196 AZUMIO: BUSINESS OVERVIEW
11.1.23 DECIDE CLINICAL SOFTWARE GMBH
TABLE 197 DECIDE CLINICAL SOFTWARE GMBH: BUSINESS OVERVIEW
11.1.24 PENDIQ GMBH
TABLE 198 PENDIQ GMBH: BUSINESS OVERVIEW
11.1.25 BEATO
TABLE 199 BEATO: BUSINESS OVERVIEW
*Details on Business overview, Products & services offered, Recent developments, MnM view, Right to win, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX (Page No. – 227)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
